Cases screener

Two adverse events occurred on April 26, 2022. First, the CEO of Novartis AG, Vas Narasimhan, announced that EUA approval or a general a...

On August 12, 2022, Latch, Inc. announced that it received a letter from the Listing Qualifications Department of Nasdaq notifying the Co...

Bloomberg reported that "Okta Inc., a maker of identity-verification software, agreed to buy smaller rival Auth0 for about $6.5 billion i...

On August 31, 2022, Okta released Q2 2022 earnings report and disclosed that it was having challenges integrating Auth0, the customer ide...

On August 30, PVH Corp. released Q2 2022 financials and surprised the market by cutting full-year projections. At the same time, the Com...

On March 8, 2022, Stitch Fix provided a weak outlook for its Q3 2022 and cut its revenue guidance for the full year. Also, Stitch Fix ann...

On July 13, 2022, The Korea Times published an article reporting that Coupang was under investigation for falsely advertising the members...

There are grounds to suspect that the Company disclosed information in bad faith as part of the initial offering in March 2021, including...

On August 29, 2022, the Company disclosed among other things that " it received a whistleblower complaint in May 2022 alleging potential ...

On July 28, 2022, Consumer Financial Protection Bureau (CFPB) Fines U.S. Bank $37.5 Million for Illegally Exploiting Personal Data to Ope...

On August 29, 2022, Reuters reported that "Elon Musk has sent an additional letter of deal termination to Twitter Inc to include a recent...

According to the SEC filing on April 4, 2022, Block, Inc. announced a data breach and among other things: " it recently determined that a...

On June 15, 2022, CNBC published an article “Sen. Warren asks bank regulator to reject TD’s $13.4 billion acquisition after customer-abu...

On April 18, 2022, The Wall Street Journal released an article stating that "Arqit has given investors an overly optimistic view of its f...

On November 16, 2021, the company disclosed that "a planned futility analysis of ensovibep in [an] ongoing [Phase 3] clinical study . . ....

On July 25, 2022, WWE filed the SEC report which announced that “the Company has made a preliminary determination that certain payments t...

On July 25, 2022, WWE filed the SEC report which announced that “the Company has made a preliminary determination that certain payments t...

On March 17, 2022, a Beijing News reported that Chinese regulators launched a probe into Dingdong for food safety violations uncovered by...